COVID-19 and return to campus information.
University of California, Riverside
Follow US:
UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells
